Serum Sex Hormone Levels and Subclinical Atherosclerosis - Ancillary to MESA

NCT00064532 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 6173

Last updated 2014-12-03

No results posted yet for this study

Summary

To assess the associations of serum sex hormones with the presence and progression of subclinical atherosclerosis.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Susan Gapstur · Northwestern University

Eligibility

Min Age
45 Years
Max Age
84 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2008-06-30
Completion
2008-06-30

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00064532 on ClinicalTrials.gov